These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 16960831

  • 21. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment.
    Wang Y, Challa P, Epstein DL, Yuan F.
    Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918
    [Abstract] [Full Text] [Related]

  • 22. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD, Rajkannan R, Selvaraj D, Jayakumar R, Vamsadhara C.
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [Abstract] [Full Text] [Related]

  • 23. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC, Poff J, Cortés ME, Sinisterra RD, Faris CB, Hildgen P, Langer R, Shastri VP.
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [Abstract] [Full Text] [Related]

  • 24. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, Na SK, Roh SH, Kim SI, Nah JW.
    Int J Pharm; 2008 Mar 20; 352(1-2):317-23. PubMed ID: 18160236
    [Abstract] [Full Text] [Related]

  • 25. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK, Venkatraman SS, Boey FY, Cadart S, Loo JS.
    J Biomed Mater Res A; 2008 Mar 15; 84(4):980-7. PubMed ID: 17647238
    [Abstract] [Full Text] [Related]

  • 26. Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system.
    Wang Tw, Xu Q, Wu Y, Zeng Aj, Li M, Gao H.
    Carbohydr Res; 2009 May 12; 344(7):908-14. PubMed ID: 19303066
    [Abstract] [Full Text] [Related]

  • 27. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB, Kissel T.
    J Control Release; 2007 Nov 06; 123(2):131-40. PubMed ID: 17854938
    [Abstract] [Full Text] [Related]

  • 28. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
    Weiss B, Schneider M, Muys L, Taetz S, Neumann D, Schaefer UF, Lehr CM.
    Bioconjug Chem; 2007 Nov 06; 18(4):1087-94. PubMed ID: 17590034
    [Abstract] [Full Text] [Related]

  • 29. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
    Cho KY, Lee S, Park JK.
    Macromol Biosci; 2007 Jun 07; 7(6):784-8. PubMed ID: 17541923
    [Abstract] [Full Text] [Related]

  • 30. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.
    De Rosa G, Larobina D, Immacolata La Rotonda M, Musto P, Quaglia F, Ungaro F.
    J Control Release; 2005 Jan 20; 102(1):71-83. PubMed ID: 15653135
    [Abstract] [Full Text] [Related]

  • 31. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS, Carson KH, Rice-Ficht AC, Andrews MJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):118-26. PubMed ID: 17289316
    [Abstract] [Full Text] [Related]

  • 32. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW, Kim JH.
    J Control Release; 2007 Sep 11; 122(1):24-30. PubMed ID: 17628158
    [Abstract] [Full Text] [Related]

  • 33. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles.
    Dillen K, Weyenberg W, Vandervoort J, Ludwig A.
    Eur J Pharm Biopharm; 2004 Nov 11; 58(3):539-49. PubMed ID: 15451528
    [Abstract] [Full Text] [Related]

  • 34. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
    Ghera BB, Perret F, Chevalier Y, Parrot-Lopez H.
    Int J Pharm; 2009 Jun 22; 375(1-2):155-62. PubMed ID: 19481701
    [Abstract] [Full Text] [Related]

  • 35. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S, Zhang X, Teng D, Wang Z, Li C.
    Carbohydr Res; 2009 Jul 06; 344(10):1197-204. PubMed ID: 19508912
    [Abstract] [Full Text] [Related]

  • 36. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
    He W, Horn SW, Hussain MD.
    Int J Pharm; 2007 Apr 04; 334(1-2):173-8. PubMed ID: 17101249
    [Abstract] [Full Text] [Related]

  • 37. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.
    Pollauf EJ, Berkland C, Kim KK, Pack DW.
    Int J Pharm; 2005 Sep 14; 301(1-2):294-303. PubMed ID: 16051452
    [Abstract] [Full Text] [Related]

  • 38. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM.
    J Control Release; 2008 Feb 11; 125(3):193-209. PubMed ID: 18083265
    [Abstract] [Full Text] [Related]

  • 39. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
    Jin C, Bai L, Wu H, Tian F, Guo G.
    Biomaterials; 2007 Sep 11; 28(25):3724-30. PubMed ID: 17509678
    [Abstract] [Full Text] [Related]

  • 40. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB, Pan YH, Hu JH.
    Int J Pharm; 2008 Feb 12; 349(1-2):274-82. PubMed ID: 17870261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.